🇺🇸 Ezetimibe + Simvastatin in United States

872 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Diarrhoea — 126 reports (14.45%)
  2. Acute Kidney Injury — 125 reports (14.33%)
  3. Fatigue — 102 reports (11.7%)
  4. Dyspnoea — 87 reports (9.98%)
  5. Rhabdomyolysis — 80 reports (9.17%)
  6. Myalgia — 79 reports (9.06%)
  7. Drug Interaction — 78 reports (8.94%)
  8. Dizziness — 69 reports (7.91%)
  9. Nausea — 67 reports (7.68%)
  10. Asthenia — 59 reports (6.77%)

Source database →

Other Cardiovascular approved in United States

Frequently asked questions

Is Ezetimibe + Simvastatin approved in United States?

Ezetimibe + Simvastatin does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Ezetimibe + Simvastatin in United States?

Organon and Co is the originator. The local marketing authorisation holder may differ — check the official source linked above.